Biostem Investor Relations Material
Latest events
Q1 2025
Biostem
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Biostem Technologies Inc
Access all reports
BioStem Technologies Inc. is a life sciences and regenerative medicine company that focuses on developing, manufacturing, and commercializing placental-derived allografts for advanced wound care. The company uses its proprietary BioRetain process to produce perinatal tissue allografts, preserving key biological properties that support tissue regeneration. BioStem’s products are used in a range of medical applications, including wound management and tissue repair. The company's portfolio includes products such as VENDAJE, VENDAJE AC, and AmnioWrap2. The company is headquartered in Pompano Beach, Florida, and its shares are listed on the OTC market.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
BSEM
Country
🇺🇸 United States